PSL Group Executive and Leadership Team

Michele Fearon, the Chief Executive Officer at PSL Group, directs the overarching corporate strategy and operational execution across all global markets. Fearon guides the company's expansion in Europe, North America, Latin America, and Asia, ensuring alignment with the mission to provide advanced online fieldwork services. This leadership role involves fostering innovation in how pharmaceutical market research, consulting, and healthcare communication agencies engage with physicians. By integrating professional marketing messages with robust clinical evidence, Fearon ensures programs resonate effectively. The Chief Executive Officer's focus remains on driving growth and enhancing the company's international presence. Michele Fearon's strategic vision shapes the company's response to evolving healthcare communication needs.

Tim Houghton, the Chief Executive Officer, MEC Domain at PSL Group, spearheads strategic initiatives within the MEC Domain. Houghton directs the operational framework and market penetration strategies for this specific business segment, ensuring its contribution to the company's overall mission. This involves overseeing the delivery of specialized online fieldwork services tailored to the needs of pharmaceutical market research, consulting, and healthcare communication agencies. The Chief Executive Officer, MEC Domain's focus includes enhancing the integration of professional marketing messages with clinical evidence to create resonant physician programs. Tim Houghton's leadership drives the success and expansion of the MEC Domain across key international markets.

Neil Corner, the Chief Executive Officer, AI LaunchPad, PSL Group at PSL Group, leads the strategic development and execution of the AI LaunchPad initiative. Corner directs the integration of artificial intelligence technologies to enhance the company's online fieldwork services for pharmaceutical market research, consulting, and healthcare communication agencies. This involves pioneering new methods for delivering PV update programs and clinical evidence reviews. The Chief Executive Officer, AI LaunchPad, PSL Group's mandate includes exploring how AI can optimize the combination of marketing messages with clinical data to improve physician engagement. Neil Corner's vision propels the AI LaunchPad forward, ensuring PSL Group remains at the cutting edge of innovation in healthcare communications.

James Karr, the Chief Financial Officer at PSL Group, manages all financial operations and strategic fiscal planning. Karr oversees budgeting, forecasting, and financial reporting, ensuring the company's economic health and sustainable growth across its international operations. This leadership position involves optimizing financial resources to support the delivery of online fieldwork services to pharmaceutical market research, consulting, and healthcare communication agencies. The Chief Financial Officer's role is critical in evaluating investment opportunities and managing financial risks associated with global expansion in Europe, North America, Latin America, and Asia. James Karr's financial acumen underpins the company's ability to execute its mission of enhancing physician engagement through evidence-based communication.

Kristin Stockett, the Executive President, Enterprise Partnerships, Peerdirect at PSL Group, drives strategic growth through key enterprise collaborations. Stockett focuses on building and nurturing relationships with major partners, expanding the reach of PSL Group's online fieldwork services. This involves identifying opportunities to deliver PV update programs and clinical evidence reviews to a broader range of pharmaceutical market research, consulting, and healthcare communication agencies. The Executive President, Enterprise Partnerships, Peerdirect's leadership is instrumental in developing tailored solutions that combine marketing messages with clinical evidence for physician engagement. Kristin Stockett's efforts enhance PSL Group's market presence and impact across international territories.

Stephanie Kennedy-Harris, the Group President at PSL Group, oversees significant business units and drives strategic growth initiatives. Kennedy-Harris directs the performance and development of key operational groups, ensuring alignment with the company's mission to provide advanced online fieldwork services. This leadership role involves fostering collaboration across departments to deliver PV update programs and clinical evidence reviews to pharmaceutical market research, consulting, and healthcare communication agencies. The Group President's focus is on enhancing market penetration and client satisfaction globally. Stephanie Kennedy-Harris's strategic oversight contributes to the effective combination of marketing messages with clinical evidence, strengthening physician engagement.

Kim Nachbaur, the Executive President, Enterprise Partnerships at PSL Group, spearheads the development and expansion of strategic alliances. Nachbaur cultivates relationships with key enterprise clients, driving the adoption of PSL Group's specialized online fieldwork services. This involves identifying and securing opportunities to deliver PV update programs and clinical evidence reviews to pharmaceutical market research, consulting, and healthcare communication agencies. The Executive President, Enterprise Partnerships's role is crucial in ensuring that professional marketing messages are effectively integrated with clinical evidence to resonate with physicians. Kim Nachbaur's strategic focus on partnerships enhances the company's global reach and impact.

Gilbert Merariu, the Chief Information Officer at PSL Group, architects the company's technology infrastructure and digital strategy. Merariu oversees the development and implementation of online fieldwork platforms that support pharmaceutical market research, consulting, and healthcare communication agencies. This involves ensuring robust data security and efficient delivery of PV update programs and on-label education reviews. The Chief Information Officer's responsibilities extend to leveraging technology to combine clinical evidence with marketing messages, creating impactful physician communication programs. Gilbert Merariu drives technological innovation to enhance service delivery across Europe, North America, Latin America, and Asia, ensuring the company remains at the forefront of digital healthcare communications.

Christian Grenon, the Chief Operations Officer at PSL Group, oversees the day-to-day operational efficiency and service delivery across all global regions. Grenon manages the execution of online fieldwork services, ensuring the seamless provision of PV update programs and clinical evidence reviews to pharmaceutical market research, consulting, and healthcare communication agencies. This role is critical in optimizing processes that combine professional marketing messages with clinical evidence to resonate with physicians. The Chief Operations Officer's responsibilities include streamlining workflows and enhancing resource allocation to support international operations in Europe, North America, Latin America, and Asia. Christian Grenon's operational leadership ensures the consistent quality and effectiveness of PSL Group's service offerings.

Richard Woolfson, the Chief Medical Officer at PSL Group, provides critical medical and clinical oversight for the company's service offerings. Woolfson ensures that all programs, including PV update programs and reviews of key on-label education, adhere to the highest medical and scientific standards. This role is pivotal in guiding the development of communication strategies that effectively combine professional marketing messages with accurate clinical evidence for physicians. The Chief Medical Officer's expertise ensures that PSL Group's online fieldwork services for pharmaceutical market research, consulting, and healthcare communication agencies are both medically sound and impactful. Richard Woolfson's guidance strengthens the company's commitment to evidence-based healthcare communication.